Fluorometric screening for metabolism-based drug–drug interactions

This publication has 13 references indexed in Scilit:

• CYP3A4 drug interactions: correlation of 10 in vitro probe substrates
  British Journal of Clinical Pharmacology, 1999
• Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel Blockers
  JAMA, 1998
• Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active Sites
  Biochemistry, 1998
• Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450
  Analytical Biochemistry, 1997
• Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
  Drug Metabolism Reviews, 1997
• Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
  Pharmacogenetics, 1995
• The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular Modeling
  Biochemistry, 1995
• Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] Dextromethorphan
  Analytical Biochemistry, 1994
• P450 Enzymes
  Clinical Pharmacokinetics, 1992
• Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
  Nature, 1988